ALDER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 014339AA3.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $18,432,000 | +36.2% | 16,653,000 | +14.3% | 0.03% | +145.5% |
| Q2 2019 | $13,535,000 | -20.0% | 14,564,000 | -17.9% | 0.01% | -54.2% |
| Q1 2019 | $16,927,000 | +1.6% | 17,732,000 | -15.1% | 0.02% | +60.0% |
| Q4 2018 | $16,658,000 | +4.5% | 20,882,000 | +40.1% | 0.02% | -28.6% |
| Q3 2018 | $15,947,000 | -34.8% | 14,905,000 | -36.7% | 0.02% | -40.0% |
| Q2 2018 | $24,452,000 | – | 23,539,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 52,517,000 | $50,131,000 | 4.53% |
| Mohican Financial Management, LLC | 1,250,000 | $1,196,000 | 3.90% |
| Redmile Group, LLC | 25,000,000 | $23,865,000 | 0.70% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,195,000 | $30,920,000 | 0.42% |
| PFM Health Sciences, LP | 17,213,000 | $16,517,000 | 0.36% |
| SSI INVESTMENT MANAGEMENT LLC | 2,750,000 | $2,626,000 | 0.22% |
| Rock Springs Capital Management LP | 5,000,000 | $4,798,000 | 0.18% |
| Partner Investment Management, L.P. | 137,000 | $131,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,000,000 | $3,830,000 | 0.12% |
| DAFNA Capital Management LLC | 250,000 | $240,000 | 0.10% |